Scientech Research’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
Other funds holding ZNTL
OM
Scientech Research's ZNTL Position: Q2 2026 in Review
Scientech Research opened a new position in Zentalis Pharmaceuticals (ZNTL) in Q2 2026: 13,613 shares worth $66K. The stake represents 0.05% of the portfolio and ranks #189 among its holdings.
115 funds tracked by Wall St. Rank hold ZNTL as of Q2 2026.
- Scientech Research held 13,613 shares of Zentalis Pharmaceuticals worth $66K as of Q2 2026.
- Zentalis Pharmaceuticals was a new Scientech Research position in Q2 2026.
- Zentalis Pharmaceuticals made up 0.05% of Scientech Research's portfolio in Q2 2026, its #189 holding.
- 115 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.